Welcome to the

Regenera Activa Partner Portal

Access clinical evidence, training resources, marketing tools, and dedicated support, all in one place.

Book a Demo
0 + Scientific Publications​
0 + Procedures Worldwide​
0 + Countries Worldwide
0 + Years of Innovation
Regenera Activa device
CE Certified CE Certified
ISO 13485 ISO 13485
Made in Europe Made in Europe
Patented Technology Patented Technology
Registered with 30+ Authorities Registered with 30+ Authorities

3-Step Onboarding

Everything you need to get started with Regenera Activa.

1

Understand The Protocol

Learn the AMT procedure from biopsy to injection in approximately 30 minutes through a minimally invasive autologous process.

Explore
2

Review The Evidence

Access 80+ peer-reviewed publications and clinical study data.

Explore
3

Get Implementation Tools

Download marketing kits, patient brochures, and training resources.

Explore

What's New

4th World Trichoscopy Congress (ITS Rio)
Webinar
octubre 29, 2026 - noviembre 1, 2026

4th World Trichoscopy Congress (ITS Rio)

Brings together leading experts in hair and scalp science for an unforgettable scientific experience in Rio de Janeiro.

View More es

The Science Behind Regenera Activa?

Regenera Activa introduces an innovative approach to regenerative treatment for AGA with our patented medical device, engineered to obtain an injectable autologous micrograft solution called AMT® Triad. This solution contains progenitor cells, extracellular matrix components, and extracellular vesicles derived from autologous tissue. It is obtained from a healthy scalp tissue sample typically harvested from the retroauricular region.

Utilizing a mechanical disaggregation process, the biopsies are transformed into a solution that is then injected into areas with impaired or damaged tissue. This approach is designed to support the biological processes involved in hair follicle regeneration, harnessing the patient’s own tissue components to support natural hair growth.

The entire procedure, including biopsies obtention, disaggregation and ingrafting, takes approximately 30 minutes. Clinical studies have reported improvements in hair parameters following a single treatment session, while the autologous and minimally manipulated nature of the procedure contributes to a favorable safety profile.

Clinical evidence has demonstrated improvements in hair density and thickness, supporting the use of autologous micrografts as part of a comprehensive treatment strategy for androgenetic alopecia.  

The Power of personalized Regeneration with Human Smart Exosomes:

The Essence of Smart Exosomes:

We’ve precisely quantified up to 70 billions* Human Smart Exosomes in our AMT® Triad. This breakthrough confirms their autologous nature and tissue-specific function, offering personalized regeneration.

These extracellular vesicles carry biological signals derived from the patient’s own tissue, supporting individualized regenerative processes.

 

  • The first injectable autologous and tissue-specific in the market
  • Personalized agents to modulate inflammation and healing​
  • Minimally manipulated autologous tissue with a favorable safety profile​
  • Supported by peer-reviewed scientific evidence​

Quantity depending on the protocol applied and patient variables.

Download Exosomes Trifold

Need to Speak with the Right Person?

Our sales and medical teams are organized by region. Select your country and we’ll route you to the right contact.